drugset / Trial / NCT00335972

The Effects of Dexmedetomidine and Remifentanil on Carotid Patients

NCT00335972 ↗

Phase 4 Terminated 142 enrolled The Cleveland Clinic
RandomizedParallel-groupTriple-blindPrevention

Summary

We propose to test whether intraoperative administration of dexmedetomidine will reduce hemodynamic control in the intra- and post-operative periods and reduces PACU analgesic requirements in patients undergoing carotid endarterectomy.

Timeline

Start
2006-06
Primary completion
2008-05
Completion
2008-05

Outcome

Outcome not reported

Stopped (Enrollment): “Closed due to lack of enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg —
Comparator Remifentanil Small molecule 0.1 ug/kg —
Comparator Remifentanil Small molecule 0.2 ug/kg —

Indications